EGFR mutation + BCL2L11 deletion

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR mutation + BCL2L11 deletion	Non Small Cell Lung Cancer	EGFR mutation + BCL2L11 deletion	Non Small Cell Lung Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
EGFR mutation + BCL2L11 deletion	Non Small Cell Lung Cancer	EGFR mutation + BCL2L11 deletion	Non Small Cell Lung Cancer	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3

Associations